SUBSIDIARY OF KING PHARMACEUTICALS AGREES TO PAY UP
The U.S. Justice Department says a subsidiary of Bristol, Tenn.-based King Pharmaceuticals Inc. has agreed to pay $42.5 million to settle allegations over the marketing of a painkiller. Prosecutors announced…